Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
Immature Arteriovenous Fistula
About this trial
This is an interventional treatment trial for Immature Arteriovenous Fistula focused on measuring immature AVF, percutaneous intervention
Eligibility Criteria
Inclusion Criteria:
- Patients with End stage renal disease (ESRD).
- Patients on hemodialysis.
- Patients using central venous catheter (CVC).
- Patients who had a new AVF created after commencing dialysis.
- Patients who had immature fistula ( 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min).
Exclusion Criteria:
• Children with Age below 18
Sites / Locations
- UAB
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
early angioplasty
late Angioplasty
Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who an early angioplasty intervention group that will undergo a routine Angioplasty at 6 weeks after AVF creation
Patients who initiated hemodialysis with a CVC, then had a new AVF created after commencing dialysis, and then had a 6-week postoperative ultrasound that revealed an immature AVF (diameter < 4 mm diameter or blood flow < 500 ml/min). These patients who a late angioplasty intervention group in which early Angioplasty will be avoided and subsequently be performed only if the 3-month ultrasound indicates persistent AVF immaturity